Aarti Pharmalabs Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2025
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has notified the stock exchanges about its 6th Annual General Meeting scheduled for Monday, September 22, 2025, at 11:00 a.m. via video conferencing. Along with the AGM notice, the company has filed its Annual Report for FY 2024-25. The report highlights the company's best-ever financial performance, with operational revenue growing 14.3% to Rs 2,115 Crores, EBITDA up 20% to Rs 464 Crores (20.84% margin), and Profit After Tax rising 26% to Rs 272 Crores. The company also announced a dividend of Rs 5 per equity share, totalling Rs 45 Crores in outflow, and disclosed capex of Rs 391 Crores during the year, primarily for the Atali greenfield plant and Xanthine capacity expansion from 5,000 to 9,000 MTPA.
This is primarily a procedural filing informing shareholders about the AGM where they can vote on key matters including the financial statements and dividend. The strong FY25 results, healthy dividend, and CRISIL credit rating upgrade to AA-/Stable signal financial strength, while the AGM date allows shareholders time to participate in e-voting before September 22, 2025.